BCT.TO
Price:
$15.8
Market Cap:
$21.50M
BriaCell Therapeutics Corp., an immuno-oncology-focused biotechnology company, engages in developing immunotherapies for the management of cancer. Its lead drug candidate is Bria-IMT, a whole-cell cancer vaccine that is in Phase I/IIa clinical trials in combination with the immunotherapy development candidates retifanlimab. The company is also developing Bria-OTS, an off-the-shelf personalized immunotherapy for advanced breast cancer; and BriaDx, a diagnostic test that determines the patients' HLA types. It has a non-exclusive clinical trial collaboration with Incyte Corporation to evaluate the effects of combinations of novel clinical candidates; and a cooperative research and development a...[Read more]
Industry
Biotechnology
IPO Date
2012-08-13
Stock Exchange
TSX
Ticker
BCT.TO
According to BriaCell Therapeutics Corp.’s latest financial reports and current stock price. The company's current ROE is -439.74%. This represents a change of 455.70% compared to the average of -79.13% of the last 4 quarters.
The mean historical ROE of BriaCell Therapeutics Corp. over the last ten years is -41.23%. The current -439.74% ROE has changed 966.57% with respect to the historical average. Over the past ten years (40 quarters), BCT.TO's ROE was at its highest in in the January 2023 quarter at 927.86%. The ROE was at its lowest in in the April 2019 quarter at -227.49%.
Average
-41.23%
Median
-23.55%
Minimum
-344.44%
Maximum
537.49%
Discovering the peaks and valleys of BriaCell Therapeutics Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 2.12%
Maximum Annual ROE = 537.49%
Minimum Annual Increase = -4442.79%
Minimum Annual ROE = -344.44%
| Year | ROE | Change |
|---|---|---|
| 2024 | 0.28% | -99.95% |
| 2023 | 537.49% | -579.38% |
| 2022 | -112.12% | 2.12% |
| 2021 | -5.06% | -87.97% |
| 2020 | -42.04% | -4442.79% |
| 2019 | 0.97% | -269.02% |
| 2018 | -0.57% | -99.83% |
| 2017 | -344.44% | 59.89% |
| 2016 | -215.42% | -6.90% |
| 2015 | -231.37% | -80.44% |
The current ROE of BriaCell Therapeutics Corp. (BCT.TO) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
141.88%
5-year avg
75.71%
10-year avg
-41.23%
BriaCell Therapeutics Corp.’s ROE is less than Resverlogix Corp. (6.06%), greater than Perimeter Medical Imaging AI, Inc. (-190.26%), less than Rapid Dose Therapeutics Corp. (105.94%), less than Gemina Laboratories Ltd. (107.27%), less than Pangenomic Health Inc. (88.94%), greater than Telescope Innovations Corp. (-33.79%), greater than Greenway Greenhouse Cannabis Corporation (-16.77%), less than Hemostemix Inc. (68.24%), less than Izotropic Corporation (67.02%), less than Microbix Biosystems Inc. (-1.11%),
| Company | ROE | Market cap |
|---|---|---|
| 6.06% | $33.04M | |
| -190.26% | $21.38M | |
| 105.94% | $20.59M | |
| 107.27% | $16.85M | |
| 88.94% | $9.13M | |
| -33.79% | $18.53M | |
| -16.77% | $22.48M | |
| 68.24% | $14.88M | |
| 67.02% | $20.32M | |
| -1.11% | $33.66M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BriaCell Therapeutics Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like BriaCell Therapeutics Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is BriaCell Therapeutics Corp.'s ROE?
How is the ROE calculated for BriaCell Therapeutics Corp. (BCT.TO)?
What is the highest ROE for BriaCell Therapeutics Corp. (BCT.TO)?
What is the 3-year average ROE for BriaCell Therapeutics Corp. (BCT.TO)?
What is the 5-year average ROE for BriaCell Therapeutics Corp. (BCT.TO)?
How does the current ROE for BriaCell Therapeutics Corp. (BCT.TO) compare to its historical average?